Detailed View
ELTP - Elite Pharmaceuticals, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
323,140,928
Adj EBIT (TTM)
35,066,936.10
Enterprise Value
324,275,271
Last Price
0.30
Earnings Yield
10.81%
Return on Capital
33.58%
Capital
104,436,728
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2027 | 32,355,283 | 7,529,281 |
| 2026-03-31 | 10-K (Q4 derived) | 2026 | 40,748,067 | 10,186,788 |
| 2025-12-31 | 10-Q | 2026 | 31,589,251 | 9,012,943 |
| 2025-09-30 | 10-Q | 2026 | 36,321,704 | 8,213,746 |
| 2025-06-30 | 10-Q | 2026 | 40,211,097 | 21,699,707 |
| 2025-03-31 | 10-K (Q4 derived) | 2025 | 31,996,273 | 11,153,659 |
| 2024-12-31 | 10-Q | 2025 | 14,364,248 | 1,097,810 |
| 2024-09-30 | 10-Q | 2025 | 18,880,345 | 3,484,943 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.